ARGS
Argos Therapeutics, Inc.
ARGS
ARGS
Delisted
ARGS was delisted on the 24th of April, 2018.
28 hedge funds and large institutions have $456K invested in Argos Therapeutics, Inc. in 2017 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
84% less capital invested
Capital invested by funds: $2.89M → $456K (-$2.44M)
Holders
28
Holding in Top 10
1
Calls
$615K
Puts
–
Top Buyers
| 1 | +$32.6K | |
| 2 | +$10.9K | |
| 3 | +$6.71K | |
| 4 |
SMH
Sanders Morris Harris
Houston,
Texas
|
+$4.86K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$3.37K |
Top Sellers
| 1 | -$32K | |
| 2 | -$17.1K | |
| 3 | -$16.7K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$15.7K |
| 5 |
Bank of New York Mellon
New York
|
-$8.44K |